Monoclonal antibodies targeting EGFR/HER2 and clinical outcomes in cancer treatment. (©2013)

• Record Type: Book
• Further Information: Note: Editor, Jan B. Vermorken.
• Other Names: Vermorken, Jan B; Future Medicine Ltd.
• Contents: Monoclonal antibodies targeting EGFR/HER2 and clinical outcomes in cancer treatment / Jan B. Vermorken -- Colorectal cancer / Christian Rolfo, Giuseppe Bronte, Antonio Russo & Marc Peeters -- Breast cancer / Sevilay Altintas -- Lung cancer and genitourinary cancers / Dirk Schrijvers -- Tumors of the skin, the CNS and the head and neck / Pol Specenier -- Gynecologic cancers / Jan B. Vermorken -- Index.
• Publisher Details: London, England : Future Medicine Ltd (Unitec House, 2 Albert Place, London N3 1QB, UK)
• Publication Date: 2013
• Copyright Date: 2013
• Extent: 1 electronic text (107 pages), color illustrations, digital file
• Subjects: 616.99/40642; Monoclonal antibodies -- Therapeutic use; HER-2 gene; HER-2 protein; Epidermal growth factor; Cancer -- Chemotherapy; Antibodies, Monoclonal -- therapeutic use; Receptor, ErbB-2; Receptor, Epidermal Growth Factor; Neoplasms -- drug therapy; Cancer -- Chemotherapy; Epidermal growth factor; HER-2 gene; HER-2 protein; Monoclonal antibodies -- Therapeutic use; Electronic books
• Languages: English
• ISBNs: 9781780843278; 1780843275; 9781780843285; 1780843283
• Related ISBNs: 9781780843292
• Notes: Note: Includes bibliographical references and index.
• Access Rights: Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
• Access Usage: Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.